Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral hepatitis in India.

S K Acharya1, Kaushal Madan, S Dattagupta

  • 1Department of Gastroenterology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India. subratacharya2004@yahoo.com

The National Medical Journal of India
|November 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of different Processing Methods on the reduction of Oxytetracycline residues in Tilapia (Oreochromis niloticus).

Journal of AOAC International·2026
Same author

Does active case finding detect TB early in programme settings? A national-level study in India.

Public health action·2026
Same author

Acute-on-chronic liver failure due to hepatitis B.

Frontiers in gastroenterology (Lausanne, Switzerland)·2026
Same author

Indian National Association for Study of the Liver Guidance Document on Difficult to Treat Autoimmune Hepatitis.

Journal of clinical and experimental hepatology·2026
Same author

To Biopsy or Not to Biopsy? Re-examining the Role of Tissue Diagnosis in Hepatocellular Carcinoma.

Journal of clinical and experimental hepatology·2025
Same author

Investigating dust storm dynamics and lightning interactions using Weather Research Forecasting-Chemistry (WRF-CHEM) model over India.

The Science of the total environment·2025

Viral hepatitis, including Hepatitis A (HAV) and E (HEV), poses a significant public health challenge in India. Preventive strategies and a national hepatitis registry are crucial for control.

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Viral hepatitis is a major public health concern in India, with high endemicity for Hepatitis A virus (HAV) and Hepatitis E virus (HEV).
  • Hepatitis B virus (HBV) shows intermediate endemicity, while Hepatitis C virus (HCV) affects approximately 1% of the population.
  • Hepatitis D virus (HDV) is infrequent, but hepatocellular carcinoma (HCC) is less common than expected given HBV and HCV prevalence.

Purpose of the Study:

  • To outline the epidemiology of viral hepatitis in India.
  • To highlight the significant disease burden and identify high-risk groups for specific viral hepatitis infections.
  • To emphasize the need for targeted prevention and control strategies.

Main Methods:

  • Review of seroprevalence studies for HAV, HEV, HBV, HCV, and HDV in India.

Related Experiment Videos

  • Analysis of transmission routes and risk factors associated with each hepatitis virus.
  • Assessment of the impact of viral hepatitis on liver disease, including chronic liver disease (CLD) and HCC.

    • Main Results:

    • HAV and HEV are hyperendemic, with near-universal HAV immunity by adolescence; HEV is a major cause of acute viral hepatitis and ALF in adults.
    • HBV infection is acquired in childhood, leading to CLD and HCC, necessitating HBV vaccination.
    • HCV, prevalent at 1%, is linked to transfusions and unsterile syringes, contributing to CLD and HCC.

    Conclusions:

    • Urgent need for a national hepatitis registry and government-supported prevention and control strategies in India.
    • Targeted preventive measures are essential for high-risk groups, such as pregnant women and individuals with CLD, particularly for HEV infection.
    • Childhood HBV vaccination is crucial to reduce carrier frequency and disease burden.